We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clinical Trial for New Anti-obesity Drug Set to Launch

News   Jul 10, 2019 | Original story from The Alberta Diabetes Institute

 
Clinical Trial for New Anti-obesity Drug Set to Launch

Dr. Andrea Haqq (left) is leading the Canadian component of an international clinical trail to test an anti-obesity drug for patients with rare genetic disorders linked to obesity. Credit: University of Alberta

 
 
 

RELATED ARTICLES

The Diverse Origins of the Contemporary Population

News

A new genetic study carried out at the University of Helsinki and the University of Turku demonstrates that, at the end of the Iron Age, Finland was inhabited by separate and differing populations, all of them influencing the gene pool of modern Finns

READ MORE

Role for Dopamine in Gene Transcription and Cell Proliferation

News

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study.

READ MORE

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE